StockNews.AI
TNDM
StockNews.AI
2 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

1. Pomerantz LLP is investigating Tandem for potential securities fraud. 2. Malfunctions in insulin pumps could lead to serious medical issues. 3. Tandem's stock fell nearly 20% following the safety alert. 4. Investors are advised to join the class action investigation.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The investigation and safety concerns severely undermine investor confidence. Given the substantial price drop post-announcement, similar historical events have caused long-term damage to stock valuations.

How important is it?

The investigation directly involves TNDM, affecting investor trust and future performance. Past recalls have shown significant market reactions.

Why Short Term?

Immediate investor sentiment is negatively impacted, but effects may dissipate over time like past recalls. Historical cases show long-term price recovery is possible, albeit slowly.

Related Companies

MDTABTSYK
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.           The investigation concerns whether Tandem and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action]           On August 7, 2025, Tandem disclosed that a malfunction had been identified in certain of the Company's insulin pumps. The malfunction could "trigger an error resulting in a discontinuation of insulin delivery," which "could result in hyperglycemia due to discontinuation of insulin delivery" and "may require hospitalization or intervention from a medical professional."            On this news, Tandem's stock price fell $2.87 per share, or 19.94%, to close at $11.52 per share on August 7, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.   CONTACT:Danielle PeytonPomerantz LLP[email protected]646-581-9980 ext. 7980 SOURCE Pomerantz LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News